Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHA:603139)

China flag China · Delayed Price · Currency is CNY
30.07
-1.39 (-4.42%)
Jul 30, 2026, 3:00 PM CST
Market Cap3.14B +38.2%
Revenue (ttm)443.29M -20.2%
Net Income-295.33M
EPS-2.97
Shares Out 99.88M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,250,400
Open31.31
Previous Close31.46
Day's Range30.00 - 31.71
52-Week Range19.91 - 46.92
Beta0.54
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About SHA:603139

Shaanxi Kanghui Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical intermediates in China. It is involved in the research, development, production, and sale of traditional Chinese medicine preparations; research and development of prepared slices of Chinese medicinal herbs and pharmaceutical intermediates; and pharmaceutical distribution of biological products, blood products, pharmaceuticals, and traditional Chinese medicine. The company also provides products for the treatment of dermatologic... [Read more]

Sector Healthcare
Founded 1999
Employees 804
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603139
Full Company Profile

Financial Performance

In 2025, SHA:603139's revenue was 471.29 million, a decrease of -16.09% compared to the previous year's 561.63 million. Losses were -333.45 million, 272.1% more than in 2024.

Financial Statements